Terminalia catappa Linn. is known for its nutritional fruit and possesses medicinal benefits as well. This is a comprehensive review of the phytoconstituents and pharmacological benefits. T. catappa has been recognized for its medicinally essential phytoconstituents, such as phenol, flavonoid, and carotenoid. Numerous pharmacological investigations have confirmed this plant's ability to exhibit antimicrobial, anti-inflammatory, antidiabetic, antioxidant, hepatoprotective, and anticancer activities, all of which support its traditional uses.
INTRODUCTION
Terminalia catappa Linn. (Combretaceae) is native to Southeast Asia. The generic name originates from the Latin "terminalis," referring to the leaves teeming at the ends of the shoots. It is a large tree that grows well in subtropical and tropical climates. It is widely planted throughout the tropics. This tree is grown for its ornamental purposes and its edible nuts. The nut kernel can be eaten raw.
T. catappa is a well-recognized herb in Ayurveda. The juice of its fresh leaves is used in the preparation of medicinal lotion for leprosy and scabies, and it is taken internally for stomachache and headache. Scientific studies on the medicinal benefits of T. catappa began untimely and the reports uphold a tradition of repeating the data for each decade . It is necessary to develop a system to use the plant continuously for the most effective health care purposes. This review focused on the phytochemical and pharmacological benefits of T. catappa from the Internet database PubMed and the most relevant articles were considered for review [ Table 1 ].
A, and terflavin B. The seeds contain carbohydrates, protein, fat, fiber, iron, ascorbic acid, arachidic acid, β-carotene, linoleic acid, myristic acid, oleic acid, palmitic acid, palmitoleic acid, stearic acid, phosphorus, potassium, niacin, riboflavin, thiamin, and water. The fruit contains glucose, pentosans, corilagin, brevifolin carboxylic acid, β-carotene, cyanidin-3-glucoside, ellagic acid, gallic acid, and tannin. [3] Shikhamandloi et al. [4] identified quercetin in the leaf of T. catappa. The phytoconstituents like flavonoids, carotenoids, and phenolic compounds may be responsible for the traditional use of this plant.
Antimicrobial activity
Harmful microorganisms are the agents for many diseases and deaths. Many medicines are available but have some harmful side effects. To overcome this problem, many natural sources are available.
The chloroform as well as methanolic extracts show good antimicrobial activity against Gram-positive and Gram-negative microorganisms. The chloroform root extract of T. catappa shows antimicrobial activity against Escherichia coli and Staphylococcus aureus while petroleum root ether extract of T. catappa is devoid of antimicrobial activity. The methanolic root extract of T. catappa exhibits minimal inhibition concentration (MIC) of 0.065 mg/ml against Escherichia coli and the chloroform extract exhibits MIC of 0.4 mg/ml against Staphylococcus aureus. [5] The aqueous and methanolic extracts of the leaves of The methanolic extract is significantly more efficient than the aqueous extract in inhibiting the investigated microbial strains. [6] Shikhamandloi et al. [4] found that the methanolic extract shows antifungal activity against Curvularia lunata, Aspergillus niger, Penicillium chrysogenum, and Trichophyton tonsurans.
Taganna et al. [7] found that the leaves of T. catappa are rich in tannin components and are able to inhibit certain phenotypic expression of quorum sensing (QS) in some test strains. Akharaiyi et al. [8] conducted the work on antibacterial activity of T. catappa. Leaves in different stages are extracted by using water and are used against various harmful microorganisms. The results show that T. catappa leaves have the capacity to be active against various organisms. Anti-inflammatory, analgesic, and modulatory activity Recently, special importance has been given to the role of inflammation in the pathogenesis of various ailments. Medicinal plants are used worldwide as a remedy for various inflammatory disorders. The various polyphenolic compounds, triterpenoids, and other chemical compounds found in the plants may be responsible for the anti-inflammatory activities.
Ethanolic leaf extracts of T. catappa exhibit anti-inflammatory effect on 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced ear edema in both acute and chronic animal models. A bioassay-based fractionation procedure shows that the activity concentrates on the fraction of chloroform and the fraction has ursolic acid (1) and 2alpha, 3beta, 23-trihydroxyurs-12-en-28-oic acid (2) and also exhibits strong anti-inflammatory activities. [9] Aimola et al. [10] isolated a novel fetal hemoglobin-inducing compound (T. catappa distilled water active fraction) from the leaves of T. catappa, which work synergistically, and recommended a dual modulatory effect on inherent erythropoiesis. Ratnasooriya et al. [11] found that the extract form of tender leaves have anti-inflammatory as well as analgesic activities without affecting the estrous cycle, and also found that dosage does not induce sedation.
Wound-healing activity
A wound is the loss or breaking of cellular and functional ability of the living tissues. Resistance to drugs and toxicity of drugs delayed the advancement of synthetic antimicrobial agents to treat wounds. Several plants with effective pharmacological activities may offer healthier alternative treatments for wounds. Khan et al. [12] suggested that the application of T. catappa ointment on the wound shows 97% reduction in the wound area when compared with control (81%) and betadine ointment as the standard drug. T. catappa ointment induces the epithelization faster and this suggests that the bark extracts promote considerable wound-healing activity.
Antidiabetic activity
The prevalence of diabetes is rapidly increasing in both developing and developed countries. [13] Diabetes produces disturbances in carbohydrate, protein, and lipid metabolism. Scientific records recommended that the natural medicines originating in plants could represent culturally relevant complementary or alternative treatments as well as offer good clinical opportunities and also serve in the search for new antidiabetic agents with hypolipidemic potential.
Nagappa et al. [14] evaluated the antidiabetic potential of T. catappa fruits with different extracts (aqueous, methanol, and petroleum ether) on the levels of fasting blood sugar and various serum biochemical parameters in a diabetic rat induced by alloxan. There is a significant antidiabetic activity shown in all the three extracts at dosage levels 1/5 th of their lethal doses. Histopathological studies of the pancreas of these animals revealed a notable regeneration with aqueous and methanolic extracts, which were previously necrosed by alloxan. The aqueous and cold extract of fresh and tender leaves of T. catappa has the capacity to decrease the high blood glucose level and lipids in alloxan-induced animal models. Simultaneously, histopathologial studies support its antidiabetic potential. [15] T. catappa fruit extract and T. catappa fallen dry leaf decoction have also been reported to have hypocholesterolemic effects on rats. [16] Methanolic extract of T. catappa leaf extract exhibits the dosage-dependent increase in inhibitory effect on α-glucosidase enzyme (up to 73.2%) and α-amylase enzyme (up to 54.04%). [17] Antioxidant and radical scavenging activity The antioxidant defense in our body can merely defend itself when the free radicals are within the normal level. Great effort has been made to focus on using the available experimental techniques to identify the natural antioxidants from plants. The results promise benefits in the prevention as well as in the therapy for many life-threatening diseases.
The concurrent pretreatment of the Chinese hamster ovary-K1 (CHO-K1) cells with the aqueous extract of T. catappa leaf considerably suppresses mitomycin C-induced micronuclei. It also inhibits lipid peroxidation (LPO) and hydrogen peroxide formation induced by TPA in human mononuclear leukocytes in a dose-dependent manner. [18] Lin et al. [19] found that treatment with the aqueous extracts of T. catappa exhibited antihepatotoxic activity against carbon tetrachloride (CCl 4 )-induced toxicity in the rat. The crude drug revealed antioxidant property in FeCl 2 -ascorbic acid-induced LPO in the liver homogenate. In addition, the superoxide radical scavenging effects of T. catappa using electron spin resonance and spin trapping technique indicate that T. catappa exhibits good superoxide radical scavenger activity and antihepatotoxic activity.
Lin et al. [20] stated that the multiple antioxidant effects of the tannin components from T. catappa have the capability to prevent LPO, formation of superoxide, and their free radical scavenging activity. Punicalin and punicalagin are the most copious phytoconstituents and have the effective antioxidant activity of T. catappa.
Ko et al. [21] isolated squalene from the leaves and seed of T. catappa by gas chromatography-mass spectrometry and high-performance liquid chromatography spiking analyses in supercritical carbon dioxide (CO 2 ). The leaf extracts of T. catappa show strong 2,2-Diphenyl-1-picrylhydrazyl (DPPH) scavenging and antioxidative activities. Conversely, the seed extracts only exhibited strong inhibition of conjugated diene hydroperoxide formation and very low DPPH scavenging activity.
Annegowda et al. [22] found that T. catappa leaves extract obtained with 40 min of sonication possessed significant polyphenolic contents when compared with 20 min and 60 min of sonication and control. The antioxidant assays also show that 40 min of the sonicated extract indicate significant vitamin C equivalent values than other different intervals of sonication and control. The polyphenolic content may be responsible for this activity.
T. catappa has been found to possess the antioxidant activity in a dose-dependent manner by DPPH assay, nirtic oxide assay, reducing power assay, and H 2 O 2 assay. [23] Hepatoprotective activity Liver is the metabolic super achiever in the body and it is the main target organ for most of the toxicants that enter the body. It plays a vital role in transforming and clearing the toxicants as well as other chemicals. [24] The reliable liver-protective drugs are explicitly insufficient. [25] Conventional knowledge of medicinal plants has constantly guided the search for new cures. T. catappa inhibits the overexpression of interleukin-6 (IL-6) gene in the liver of Chemokine (C-C motif) ligand 4 (CCl 4 )-induced mice and the alanine aminotransferase (ALT) activity is reversed. Also, histological alterations such as the infiltration of several inflammatory cells and hepatocyte swelling in injured mice are efficiently lessened by the pretreatment of T. catappa. [26] Tang et al. [27] isolated 2alpha, 3beta, 23-trihydroxyursane -12 -en-28-oic acid (DHUA) from T. catappa leaves and evaluated the superoxide radicals scavenging activity and antimitochondrial swelling activity by in vitro. DHUA (50-500 µmol/L) inhibits Ca 2+ induced mitochondrial swelling and also shows superoxide radicals scavenging activity in a dose-dependent manner. Oral pretreatment with leaves of T. catappa (20 mg/kg/d, 50 mg/kg/d, and 100 mg/ kg/d for 7 days) reverses the elevated levels of ALT serum and aspartate aminotransferase (AST), and significant morphological changes are notably lessened in D-galactosamine-induced animal model. Additionally, T. catappa leaves decrease the sensitivity of mitochondrial swelling to the exotic Ca 2+ stimulation. Incubation with T. catappa leaves extract in primary cultured hepatocytes of mice may possibly prevent the decrease in cell viability in a dose-dependent manner. It also results in both an increase in AST (1.9 fold) and a decrease in superoxide dismutase (SOD) (48%) activity in supernatant of primary cultured hepatocytes. [28] Gao et al. [1] isolated ursolic acid and asiatic acid from the chloroform extract of the leaves of T. catappa. In the acute hepatic damage test, the increased levels of ALT and AST are reversed and significant morphological changes are prevented by pretreatment with 50-100 mg/kg T. catappa leaf extract. In the hepatocyte injury experiment, the increase in ALT and AST levels in the medium of primary cultured hepatocytes induced by D-galactosamine are blocked by pretreatment with 0.05 g/L, 0.1 g/L, and 0.5 g/L T. catappa leaf extract. In addition, ursolic acid and asiatic acid show superoxide anion and hydroxyl radical scavenging activity in a dose-dependent manner. This can be the mechanism in the protection of mitochondria in the liver and the scavenging action on the free radicals.
Treatment with chloroform leaf extracts of T. catappa with the concentration of 20 mg/kg, 50 mg/kg, or 100 mg/kg significantly decreases the level of serum ALT, AST, and the level of liver LPO in CCl 4 -induced liver damage. Morphological observation also confirms the hepatoprotective effects. In addition, pretreatment with leaf extracts of T. catappa effectively prevent the disruption of mitochondrial membrane potential (14.8%),
intramitochondrial Ca 2+ overload (2.1 fold), and suppression of mitochondrial Ca 2+ -ATPase activity (42.0%). This can suggest a new mechanism of the hepatoprotective effects of T. catappa. [29] Kinoshita et al. [30] isolated chebulagic acid and corilagin as the active components from the leaves of T. catappa. Both the components exhibit a strong scavenging activity for O (2) (-) and peroxyl radicals and also inhibit the formation of reactive oxygen species from leukocytes, which is stimulated by phorbol 12-myristate acetate. The intraperitoneal administration of leaf extract or corilagin, prior to galactosamine and lipopolysaccharide administration, reduces serum ALT, AST, and glutathione S-transferase (GST) activities. This also decreases the free radical formation and LPO in mitochondria. Moreover, apoptotic events such as DNA fragmentation and the increase in caspase-3 activity in the liver of galactosamine and lipopolysaccharide induce liver injury.
Anticancer activity
In 2007, cancer caused 13% of the deaths worldwide. [31] The uncontrolled replication of DNA and the cellular division of abnormal cells lead to the progression of metastasis of cancerous tumors, which invade and destroy adjacent tissues, blood as well as the lymphatic system. Ko et al. [32] observed that supercritical CO 2 leaf extracts of T. catappa did not induce mutagenicity (at 0.5 mg/plate), whereas exhibiting strong antimutagenicity effect and they are more cytotoxic to human hepatoma cells than to normal liver cells.
Oral administration of T. catappa significantly reduces the number of aberrant crypt foci/colon/rat and β-catenin accumulated crypts/cm/rat when compared to the control group. Colonic proliferating cell nuclear antigen-labeling index is also notably lower than the control. This suggests that T. catappa has a potent short-term chemopreventive efficiency on various biomarkers of colon carcinogenesis induced by carcinogen azoxymethane and this efficiency may be related to the inhibition of the development of aberrant crypt foci and β-catenin accumulated crypts. [33] In the cultured CHO cells, the pretreatment with water extract of T. catappa leaf and its major tannin component, punicalagin, prevented gene mutations and also suppressed the generation of intracellular free radicals on bleomycin-induced genotoxicity. [34] T. catappa and punicalagin suppressed the proliferation of H-ras-transformed NIH3T3 cells in a dose-dependent manner but moderately affected the nontransformed NIH3T3 cells proliferation that indicates the selectivity of T. catappa and punicalagin. T. catappa and punicalagin treatment decreased anchorage-independent growth that may have been due to a cell cycle arrest at G0/G1 phase. Punicalagin treatment decreased the levels of intracellular superoxide and also the levels of phosphorylated c-Jun N-terminal kinase 1 (JNK1) as well as protein kinase38 (p38). This will support the chemopreventive effect of punicalagin. [35] In tumor-bearing rats, the total cholesterol, triglycerides, and very-low-density lipoprotein (VLDL) cholesterol are elevated and high-density lipoprotein (HDL) cholesterol is reduced in blood as well as in the liver and the kidney. T. catappa (500 mg/kg) markedly reverses the lipid levels to normal range and this shows antitumor and antilipidemic activities. [36] T. catappa leaf extracts inhibit the expression and activities of matrix metalloproteinase-9 (MMP-9) by the assessment of mRNA levels in hepatocellular carcinoma. This inhibition is ensued by upregulating the tissue inhibitor of metalloproteinase-1 (TIMP-1); in addition, it suppresses nuclear translocation and downregulates the DNA binding activity of nuclear factor-kappa B (NF-κB) and activator protein-1 (AP-1) on the MMP-9 promoter in Human hepato cellular carcinoma cell line (Huh 7 cells). [37] In persistence, the treatment of Huh7 cells with T. catappa notably decreases the activities of protein levels as well the mRNA levels of urokinase-type plasminogen activator (u-PA). T. catappa inhibits the transcription protein of nuclear factors stimulating protein-1 (SP-1), NF-κB, and also inhibits the effects of u-PA by decreasing the phosphorylation of the extracellular-signal-regulated kinase 1/2 (ERK1/2) pathway. These results support that the u-PA expression may be an effective therapeutic target in the T. catappa mediated suppression of hepatocellular carcinoma (HCC) metastasis. [38] The ethanloic extract of T. catappa contains total phenolics 354.02 mg/g and flavonoids 51.67 mg/g contents. T. catappa extract at two different concentrations (50 mg/kg and 200 mg/kg) increases peritoneal cell count and the life span. It also significantly decreases the solid tumor mass at 200 mg/kg when compared with Ehrlich ascites carcinoma (EAC)-tumor-bearing mice. The red blood cell count, white blood cell count, hemoglobin content, and protein amount are normal in extract-treated mice. T. catappa significantly increases the levels of SOD and catalase (CAT), and decreases LPO and reduced glutathione (GSH). T. catappa exhibits antitumor activity by changing the LPO levels and the antioxidant defense may be due to the presence of phenolic and flavonoid components. [39] Treatment with T. catappa leaves may reduce the expressions of MMP-2, MMP-9, urokinase-type plasminogen activator and their endogenous inhibitors, specifically tissue inhibitor of MMP-2 and plasminogen activator inhibitor-1, in a dose-dependent manner. Further, in vivo studies also show the inhibitory effect on the growth as well as the metastasis of Lewis lung carcinoma (LLC) cells. [40] Ethanolic leaf extracts of T. catappa significantly inhibit the migration of cell and invasion capacities of squamous cell carcinoma4 (SCC4) cells. T. catappa inhibits the activities and the levels of protein in MMP-2, MMP-9, and u-PA. Further, T. catappa may inhibit the phosphorylation of JNK1/2, ERK1/2, and protein kinase B (Akt) while the expression of nuclear protein NF-κB, c-Fos, and c-Jun are also inhibited. Moreover, T. catappa decreases the DNA-binding activity with AP-1 and NF-κB. [41] Therefore, T. catappa may provide a powerful chemopreventive substance against cancer.
Antiaging activity
Hydrophilic extract of T. catappa shows DPPH-free radical scavenging activity and protects erythrocytes from hemolysis induced by 2,2'-Azobis (2-amidinopropane) dihydrochloride (AAPH). T. catappa (10-500 µg/mL) inhibits collagenase activity in a dose-dependent manner (82.3% to 101.0%) but not in elastase activity. Additionally, T. catappa inhibits MMP-1 and MMP-9 protein expression at 25 µg/mL and inhibits MMP-3 protein expression at 50 µg/mL. T. catappa also promotes the protein expression of type I procollagen. T. catappa attenuated the expression of MMP-1, -3, and -9 by inhibiting the phosphorylation of ERK, JNK, and p38. Therefore, it can be used as an antiaging agent. [42] Toxicology Azrul et al. [43] detected the primary toxicity (by lethal occurrence) and secondary toxicity (by nutritional behavior and physiological observation) of crude aqueous extract T. catappa (0.5 g/kg, 1.0 g/kg, and 3.0 g/kg) during 14 days of treatment period. No lethality is observed for the rats in the experimental period. The nutritional behavior is also in normal condition and no abnormalities are detected for physiological aspects of the rats.
